United States - English - NLM (National Library of Medicine)

aspen global inc. - chlorambucil (unii: 18d0sl7309) (chlorambucil - unii:18d0sl7309) - chlorambucil 2 mg - leukeran (chlorambucil) is indicated in the treatment of chronic lymphatic (lymphocytic) leukemia, malignant lymphomas including lymphosarcoma, giant follicular lymphoma, and hodgkin’s disease. it is not curative in any of these disorders but may produce clinically useful palliation. chlorambucil should not be used in patients whose disease has demonstrated a prior resistance to the agent. patients who have demonstrated hypersensitivity to chlorambucil should not be given the drug. there may be cross-hypersensitivity (skin rash) between chlorambucil and other alkylating agents.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

aspen pharma trading ltd - chlorambucil - oral tablet - 2mg

United States - English - NLM (National Library of Medicine)

ax pharmaceutical corp - chlorambucil (unii: 18d0sl7309) (chlorambucil - unii:18d0sl7309) - chlorambucil 9.9 g in 10 g

United States - English - NLM (National Library of Medicine)

ax pharmaceutical corp - chlorambucil (unii: 18d0sl7309) (chlorambucil - unii:18d0sl7309) - chlorambucil 99 g in 100 g

United States - English - NLM (National Library of Medicine)

bluebay shandong co.,ltd - chlorambucil (unii: 18d0sl7309) (chlorambucil - unii:18d0sl7309) -

United States - English - NLM (National Library of Medicine)

bluebay shandong co.,ltd - chlorambucil (unii: 18d0sl7309) (chlorambucil - unii:18d0sl7309) -

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - chlorambucil - oral tablet - 2mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - chlorambucil - oral tablet - 2mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

cst pharma ltd - chlorambucil - oral tablet - 2mg

United States - English - NLM (National Library of Medicine)

woodward pharma services llc - chlorambucil (unii: 18d0sl7309) (chlorambucil - unii:18d0sl7309) - leukeran (chlorambucil) is indicated in the treatment of chronic lymphatic (lymphocytic) leukemia, malignant lymphomas including lymphosarcoma, giant follicular lymphoma, and hodgkin’s disease. it is not curative in any of these disorders but may produce clinically useful palliation. chlorambucil should not be used in patients whose disease has demonstrated a prior resistance to the agent. patients who have demonstrated hypersensitivity to chlorambucil should not be given the drug. there may be cross-hypersensitivity (skin rash) between chlorambucil and other alkylating agents.